O. Behrens et al., ANTIBODY TITER AFTER ADMINISTRATION OF ANTEPARTUM RH IMMUNE PROPHYLAXIS - NORMALITY OR SENSITIZATION, Geburtshilfe und Frauenheilkunde, 53(5), 1993, pp. 342-345
Antibody screening tests were performed in 29 unsensitized pregnant wo
men after antepartum Rh immune prophylaxis, using the indirect Coombs
test (ICT) and a more sensitive ID-microtyping-system (IDM). With the
ICT, anti-D antibodies were detected in 85% for at least 4 weeks and a
t most 8 weeks after immunisation. The maximum titer was 1:8. With the
IDM, 97% showed antibodies against 'D' for at least 4 weeks and at mo
st 11 weeks with a maximum of 1:16. The IDM titer was always 1 to 3 st
eps more sensitive than the ICT. After postpartum Rh immune prophylaxi
s, anti-D titers were again positive in many of the patients (ICT: 42%
; IDM: 60%). In conclusion, it is nearly always possible to measure an
tibodies against 'D' after antepartum Rh immune prophylaxis and IDM wa
s superior in comparison to ICT. However, maternal isoimmunisation to
the rhesus antigen cannot be excluded for sure and patients have then
to be controlled. As isoimmunisation could not be confirmed in any of
our patients, postpartum Rh immune prophylaxis has to be administered
even after detection of an antibody titer against 'D' after antepartum
Rh prophylaxis.